Q4 2023 Photocure ASA Earnings Call Transcript
Good afternoon and good morning, depending on where you are on the globe. This is Dan Schneider, President, and CEO of Photocure. Today we're presenting the Photocure fourth quarter 2023 results. With me today is Erik Dahl, CFO, and David Moskowitz, Vice President of Investor Relations.
Next slide, please. Just a reminder, the normal usual disclaimers are in place for today's presentation. Next slide, please. So fourth quarter highlights for 2023, we continue to see growth and execution on key initiatives despite flexible blue light cystoscopy being discontinued worldwide by Karl Storzâs.
Product revenue grew at 20%, unit sales 4% year-over-year. From a new tower installation standpoint, there were 10 new ones opened in the fourth quarter, seven upgrades. We had 51 Saphira towers placed in 2023. This is the largest installation of rigid towers in any year since the launch of Blue Light Cystoscopy into the US.
We're executing on our plan in Europe. There were over 146 image quality upgrades. What this means is that the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
